RLH
GILD icon

RD Lewis Holdings’s Gilead Sciences GILD Stock Holding History

RD Lewis Holdings’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$232K Sell
1,630
-41
-2% -$5.74K 0.2% 84
2025
Q4 		$239K Hold
1,671
– – 0.2% 79
2025
Q3 		$206K Buy
+1,671
New +$190K 0.19% 81

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

RD Lewis Holdings's GILD Position: Q1 2026 in Review

RD Lewis Holdings reduced its Gilead Sciences (GILD) stake by 2.5% in Q1 2026, selling an estimated $5.74K and leaving 1,630 shares worth $232K. The position accounts for 0.2% of the portfolio, ranked #84.

RD Lewis Holdings first reported a position in GILD in Q3 2025 and has held it in 3 quarters since. The position peaked at $239K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • RD Lewis Holdings held 1,630 shares of Gilead Sciences worth $232K as of Q1 2026.
  • RD Lewis Holdings sold 41 Gilead Sciences shares in Q1 2026, an estimated $5.74K.
  • Gilead Sciences made up 0.2% of RD Lewis Holdings's portfolio in Q1 2026, its #84 holding.
  • RD Lewis Holdings first reported a position in Gilead Sciences in Q3 2025 and has held it in 3 quarters since.
  • RD Lewis Holdings's Gilead Sciences position peaked at $239K in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on RD Lewis Holdings's 13F filing for Q1 2026, filed 14 Apr 2026.